Acadia Pharmaceuticals ACAD Balance Sheet (2010-2026)

NASDAQ ACAD
$28.02 +0.16 (+0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Acadia Pharmaceuticals Quarterly Balance Sheet

Periods 65 quarters
Latest Jun 2026

Acadia Pharmaceuticals reported total assets of $1742.90M and total liabilities of $436.29M for the quarter ended Jun 2026, up 42.2% year over year. This balance sheet covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
94.64M147.44M204.92M139.83M154.84M114.85M290.89M107.94M98.19M188.66M204.75M177.13M155.15M319.59M217.70M253.64M258.00M177.69M282.21M384.99M
Short-term InvestmentsInvestments (Current)
445.65M373.27M241.06M296.52M281.74M301.98M111.98M267.44M247.73M250.21M265.77M323.81M410.18M436.40M463.88M508.36M589.02M641.99M569.25M571.49M
Cash & Current Investments
540.29M520.71M445.98M436.35M436.58M416.82M402.87M375.38M345.92M438.87M470.52M500.94M565.33M755.99M681.58M762.00M847.02M819.69M851.46M956.47M
Receivables - NetNet Receivables
60.70M64.37M62.71M67.95M55.73M62.20M65.92M81.85M92.80M98.27M94.70M103.70M98.21M98.74M105.74M107.50M115.85M121.46M135.35M150.64M
Receivables - OtherOther Receivables
0.97M0.98M0.77M0.94M0.40M0.89M4.33M2.30M1.73M4.08M5.38M6.70M12.15M5.96M7.97M12.18M23.59M26.77M13.03M15.69M
Receivables
61.67M65.34M63.48M68.89M56.14M63.08M70.25M84.16M94.53M102.35M100.08M110.39M110.36M104.69M113.71M119.69M139.44M148.23M148.38M166.33M
Raw Materials
6.22M6.22M6.21M6.21M5.99M5.21M5.17M6.81M16.26M31.31M53.52M63.50M42.18M69.74M76.50M83.68M77.78M82.78M74.33M67.16M
Work In Process
6.67M6.77M6.21M6.21M5.99M4.92M4.92M5.31M4.63M4.63M5.55M14.54M25.70M69.74M80.03M84.40M76.89M76.70M80.72M76.30M
Finished Goods
1.45M1.11M1.73M2.08M1.61M1.93M1.59M2.00M4.93M5.00M7.58M17.20M19.13M20.46M23.86M23.44M25.03M25.95M33.17M34.36M
Inventory
14.34M7.88M7.01M6.33M5.84M6.64M6.09M9.20M20.77M35.82M61.94M71.53M61.04M21.95M22.95M26.12M29.10M34.67M31.57M32.37M
Prepaid Assets
24.62M23.89M25.75M20.95M22.99M21.40M23.63M23.89M37.95M39.09M42.76M46.06M51.55M55.68M52.70M52.75M60.87M59.53M64.60M69.37M
Current Assets
640.92M617.82M542.22M532.52M521.55M507.94M502.85M492.63M499.17M616.12M675.30M728.92M788.28M938.32M870.94M960.55M1,076.42M1,062.11M1,096.02M1,224.55M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
8.58M8.05M7.53M7.02M6.51M6.02M5.59M5.19M4.88M4.61M4.37M4.14M3.99M4.21M3.50M3.55M3.71M7.51M14.65M17.11M
Intangibles
69.58M68.22M66.86M65.49M110.20M107.86M105.52M119.78M117.06M114.34M111.61M108.89M106.17M103.45M
Goodwill & Intangibles
69.58M68.22M66.86M65.49M110.20M107.86M105.52M119.78M117.06M114.34M111.61M108.89M106.17M103.45M
Long-Term Deferred Tax
1.20M6.80M8.70M249.88M249.62M240.68M
Other Non-Current Assets
5.77M5.77M5.77M5.77M5.77M5.77M5.77M8.12M5.77M5.77M5.77M5.77M8.77M8.77M8.77M9.47M9.47M7.84M7.85M7.85M
Non-Current Assets
76.76M82.30M82.03M80.25M80.94M79.88M152.46M150.14M133.37M132.83M179.81M185.18M188.58M249.44M261.42M265.00M254.35M502.08M509.21M518.36M
Assets
717.67M700.12M624.25M612.77M602.49M587.81M655.30M642.77M632.54M748.96M855.10M914.10M976.87M1,187.76M1,132.36M1,225.56M1,330.77M1,564.19M1,605.23M1,742.90M
Liabilities
Current Liabilities
Accounts Payables
7.72M6.88M10.77M11.85M10.01M12.75M17.42M18.81M12.31M17.54M19.33M19.88M19.08M16.19M18.09M20.10M21.75M10.90M12.25M44.57M
Payables
7.72M6.88M10.77M11.85M10.01M12.75M17.42M18.81M12.31M17.54M19.33M19.88M19.08M16.19M18.09M20.10M21.75M10.90M12.25M44.57M
Accumulated Expenses
80.50M89.19M108.83M105.83M106.56M112.88M206.88M169.13M197.29M236.71M311.26M317.97M324.86M378.68M284.44M309.93M334.84M266.21M293.28M316.87M
Other Accumulated Expenses
2.76M2.69M1.17M0.99M2.52M2.71M10.26M5.89M8.95M11.04M13.74M8.88M12.72M3.39M9.35M13.40M5.00M5.89M16.12M15.96M
Short term Debt
Current Leases
Current Taxes
0.38M8.45M8.71M7.59M8.46M
Current Deferred Revenue
Total Current Liabilities
88.22M96.07M119.60M117.68M116.57M125.63M224.30M187.94M209.60M254.25M330.60M337.85M343.94M394.87M302.53M330.02M356.58M277.11M305.52M361.44M
Non-Current Liabilities
Non-Current Deffered Revenue
Minority Interest
Operating Leases
57.68M56.13M55.48M54.69M53.77M52.70M51.44M49.78M48.10M47.80M49.19M47.19M40.42M42.04M44.63M44.60M43.03M40.55M39.00M59.55M
Other Non-Current Liabilities
4.82M7.03M4.37M5.54M6.47M9.07M30.83M9.26M12.66M15.15M11.27M12.36M15.32M18.06M19.96M28.55M13.89M19.14M12.64M15.31M
Total Non-Current Liabilities
145.90M152.19M175.08M172.37M170.34M178.32M250.22M237.72M257.71M302.05M379.79M385.04M384.37M436.91M347.16M374.62M399.61M317.67M344.53M420.98M
Total Liabilities
150.72M159.23M179.45M177.92M176.81M187.40M281.05M246.98M270.37M317.20M391.06M397.40M399.69M454.96M367.13M403.17M413.50M336.81M357.16M436.29M
Shareholder's Equity
Total Debt
Common Equity
566.96M540.89M444.80M434.85M425.69M400.41M374.26M395.79M362.17M431.75M464.04M516.70M577.18M732.79M765.24M822.38M917.27M1,227.39M1,248.07M1,306.61M
Liabilities and Shareholders Equity
717.67M700.12M624.25M612.77M602.49M587.81M655.30M642.77M632.54M748.96M855.10M914.10M976.87M1,187.76M1,132.36M1,225.56M1,330.77M1,564.19M1,605.23M1,742.90M
Retained Earnings
-2110.48M-2153.58M-2266.63M-2300.64M-2327.83M-2369.55M-2412.57M-2411.46M-2476.63M-2430.84M-2414.28M-2380.89M-2348.13M-2204.39M-2185.40M-2158.73M-2086.95M-1813.39M-1809.75M-1778.25M
Treasury Shares